Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI)

About the Cluster

More and more people in industrial nations are suffering from chronic inflammatory diseases such as Crohn’s disease, psoriasis, diabetes and rheumatism. In the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (PMI), scientists from various medical disciplines and fundamental research are working together on an interdisciplinary basis to significantly improve the diagnosis, treatment and prevention of these diseases. Their vision is to achieve complete control over the diseases – at every stage and as early as possible.

More about the Cluster of Excellence Precision Medicine in Chromic Inflammation (PMI)

 

Why precision medicine?

Preview

Cluster news

blood sample in the lab

Autoimmunity: immune cells escape therapy due to "exhausted" state

Researchers with the participation of the PMI Cluster of Excellence have succeeded in isolating and analyzing disease-causing T cells from the blood in autoimmune diseases.

 

 

Reckoned without one's host: Transmission of tuberculosis does not only depend on the pathogen

Geographical overlap between pathogen and host has a measurable influence on the transmissibility of the tuberculosis pathogen.

 
Portrait

Mathieu Groussin receives ERC grant for innovative gut microbiome research

European Research Council funds research project at Kiel University to investigate the role of bacterial extracellular vesicles in gut ecology and health with two million euros.

 

 
group photo

DFG Research Unit "miTarget" at Kiel University enters second funding phase

The German Research Foundation (DFG) is funding the Research Unit 5042 "miTarget: The microbiome as a therapeutic target in chronic inflammatory bowel diseases" for a further four years.